Stock listing

gettex:KO2 Clariane SE Aktie

German listing (gettex) of Clariane SE · home listing Euronext:CLARI

Follow Clariane SE into a list and get an email when it puts out news.

Home listing price · EURONEXT:CLARI

€3.43 EUR +0.01 (+0.2%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:CLARI

Clariane SE logo
Ticker
gettex:KO2
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
gettex
Currency
EUR

What changed lately

Calls

Replays

  • Clariane (Euronext:CLARI) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 9:00 AM ET

    Watch Transcript
  • Clariane (Euronext:CLARI) Q4 2025 Earnings Call

    Fri, Feb 27, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

All Clariane SE news

Financings

  • Unsecured euro-denominated senior notes due 2032

    Sep 8, 2026 · US$581.25M

    Announced: €500M

    Use of proceeds: Repay and cancel the €350 million term loan and €150 million real estate term loan, and pay offering fees and expenses

    Announced Sep 8, 2026

Read by 6ix AI from the company's releases

Decks

Clariane SE on 6ix

Sector
Health care
Industry
Health care services
News releases
26 in the last 12 months · 33 in all · newest Sep 21, 2026 · oldest 2025
Calls
2 calls with a replay · 2 with a transcript · latest Jul 30, 2026
Decks
12 decks · latest Jul 30, 2026

Where Clariane SE is listed

ListingExchangeCountryCurrency
Euronext:CLARI · Home listingEuronextFranceEUR
gettex:KO2 · This pagegettexGermanyEUR
LSIN:0OPSLSINUnited KingdomEUR
Stuttgart:KO2StuttgartGermanyEUR
OTC:KRNMFOTCUnited StatesUSD
Tradegate:KO2TradegateGermanyEUR
Lang & Schwarz:A0LE05Lang & SchwarzGermanyEUR
LS Exchange:A0LE05LS ExchangeGermanyEUR
Frankfurt:KO2FrankfurtGermanyEUR
Turquoise:CLARIPTurquoiseUnited KingdomEUR
Aquis:CLARIPAquisUnited KingdomEUR
Aquis:CLARIPAquisUnited KingdomEUR
BX Swiss:CLARIBX SwissSwitzerlandCHF
Dusseldorf:KO2DusseldorfGermanyEUR
Hamburg:KO2HamburgGermanyEUR

Log in to ask 6ix AI your own questions about Clariane SE.